Consortium

We have established an international consortium comprising the major large scale population-based and Type 2 Diabetes (T2D) case-control studies that exist amongst South Asians. 

Together these studies include ~90K South Asians (~20K with T2D) from a range of differing geographic and environmental settings, including non-migrant participants from India, Pakistan, and Sri Lanka, and migrant populations from the UK, the USA, Singapore and Mauritius. 

All participating cohorts have extensive clinical characterisation as well as samples of plasma and DNA for future molecular studies.




No

Participant legal name

Short name

Country

Lead Investigators

1

Imperial College of Science, Technology and Medicine

Imperial

United Kingdom

Dr John Chambers

2

Oxford University

UOXF

United Kingdom

Professor Mark McCarthy

3

Devki Devi Foundation

DDF

India

Dr Sujheet Jha

4

University of Milan

UMIL

Italy

Professor Bertazzi & Dr Bollati

5

Oulu University

OULU

Finland

Professor Marjo-Riitta Jarvelin

6

University of Helsinki

UH

Finland

Professor Janne Pitkäniemi

7

Baker IDI Heart and Diabetes Institute

BIDI

Australia

Professor Paul Zimmet

8

Cambridge University

UCAM

United Kingdom

Dr Danish Saleheen and Professor John Danesh

9

National University of Singapore

NUS

Singapore

Professor E-Shyong Tai

10

University of Kelaniya

UKEL

Sri Lanka

Professor Raj Wickremasinghe

11

CellCentric

CC

United Kingdom

Dr Neil Pegg

12

National Centre for Global Health and Medicine

NCGM

Japan

Professor Norihiro Kato

13

University of Mauritius

UoM

Mauritius

Professor Sudhir Kowlessur




Key partner strengths
  1. Large, well phenotyped South Asian T2D case-control cohorts from around the world.
  2. Investigators with track record in successful collaboration.
  3. International expertise in epidemiology, population genetics, epigenetics, bioinformatics and large scale bio-statistics.
  4. Partnerships with international consortia investigating T2D using other state of the art approaches.

Comments